These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9858217)

  • 1. CD40 regulation of death domains containing receptors and their ligands on lymphoma B cells.
    Ribeiro P; Renard N; Warzocha K; Charlot C; Jeandenant L; Callet-Bauchu E; Coiffier B; Salles G
    Br J Haematol; 1998 Dec; 103(3):684-9. PubMed ID: 9858217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
    Travert M; Ame-Thomas P; Pangault C; Morizot A; Micheau O; Semana G; Lamy T; Fest T; Tarte K; Guillaudeux T
    J Immunol; 2008 Jul; 181(2):1001-11. PubMed ID: 18606651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling.
    Smulski CR; Decossas M; Chekkat N; Beyrath J; Willen L; Guichard G; Lorenzetti R; Rizzi M; Eibel H; Schneider P; Fournel S
    Cell Death Dis; 2017 Feb; 8(2):e2601. PubMed ID: 28182009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.
    Dicker F; Kater AP; Fukuda T; Kipps TJ
    Blood; 2005 Apr; 105(8):3193-8. PubMed ID: 15339846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.
    Bugajska U; Georgopoulos NT; Southgate J; Johnson PW; Graber P; Gordon J; Selby PJ; Trejdosiewicz LK
    J Natl Cancer Inst; 2002 Sep; 94(18):1381-95. PubMed ID: 12237284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
    Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
    J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unbalanced expression of Fas and CD40 in mantle cell lymphoma.
    Clodi K; Snell V; Zhao S; Cabanillas F; Andreeff M; Younes A
    Br J Haematol; 1998 Oct; 103(1):217-9. PubMed ID: 9792311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of death receptor pathways in oncology.
    de Vries EG; Timmer T; Mulder NH; van Geelen CM; van der Graaf WT; Spierings DC; de Hooge MN; Gietema JA; de Jong S
    Drugs Today (Barc); 2003; 39 Suppl C():95-109. PubMed ID: 14988748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis.
    Lichtenstein DL; Krajcsi P; Esteban DJ; Tollefson AE; Wold WS
    J Virol; 2002 Nov; 76(22):11329-42. PubMed ID: 12388693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities.
    Léveillé C; Zekki H; Al-Daccak R; Mourad W
    Int Immunol; 1999 May; 11(5):719-30. PubMed ID: 10330277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of costimulatory molecules on follicular lymphoma cells by TNF and CD40.
    Renard N; Ribeiro P; Warzocha K; Rouvière R; Charlot C; Coiffier B; Salles G
    Leuk Lymphoma; 1999 Apr; 33(3-4):331-41. PubMed ID: 10221513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively.
    Kajiwara K; Saito A; Ogata S; Tanihara M
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):131-7. PubMed ID: 15158720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells.
    Clodi K; Wimmer D; Li Y; Goodwin R; Jaeger U; Mann G; Gadner H; Younes A
    Br J Haematol; 2000 Nov; 111(2):580-6. PubMed ID: 11122106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
    Ursini-Siegel J; Zhang W; Altmeyer A; Hatada EN; Do RK; Yagita H; Chen-Kiang S
    J Immunol; 2002 Nov; 169(10):5505-13. PubMed ID: 12421926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40-ligation-mediated protection from apoptosis of a Fas-sensitive Hodgkin's-disease-derived cell line.
    Metkar SS; Naresh KN; Redkar AA; Nadkarni JJ
    Cancer Immunol Immunother; 1998 Oct; 47(2):104-12. PubMed ID: 9769119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
    Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
    J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms.
    Ghia P; Caligaris-Cappio F
    Adv Cancer Res; 2000; 79():157-73. PubMed ID: 10818680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.
    Kabsch K; Alonso A
    J Virol; 2002 Dec; 76(23):12162-72. PubMed ID: 12414956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.